Description
AGDV is a C-terminal peptide sequence found on fibrinogen that is known as a binding site for glycoprotein IIb/IIIa (integrin αIIbβ3); this binding is required for platelet adhesion and aggregation.
AGDV is a C-terminal peptide sequence found on fibrinogen that is known as a binding site for glycoprotein IIb/IIIa (integrin αIIbβ3); this binding is required for platelet adhesion and aggregation.
Purity | ≥95% |
---|---|
Formula | C14H24N4O7 |
Formula Wt. | 360.37 |
Solubility | Soluble in water. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Srokowski EM, Woodhouse KA. Evaluation of the bulk platelet response and fibrinogen interaction to elastin-like polypeptide coatings. J Biomed Mater Res A. 2014 Feb;102(2):540-51. PMID: 23505204.
Podolnikova NP, Gorkun OV, Loreth RM, et al. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa). Biochemistry. 2005 Dec 27;44(51):16920-30. PMID: 16363805.
Liu Q, Rooney MM, Kasirer-Friede A, et al. Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads. Biochim Biophys Acta. 1998 Jun 11;1385(1):33-42. PMID: 9630497.
Piroxicam prodrug, NSAID; COX-1/2 inhibitor.
Src and Abl inhibitor.
c-MET, Tie-2, VEGFR inhibitor.
PARP1/2 inhibitor.
Thiazide diuretic; NCCT inhibitor, carbonic anh...
α3β2, α3β4, α4β2 nAChR antagonist, indire...
CDK1/2 inhibitor.
Peptide, derivative of AT I, cleavage product o...
DP1 antagonist.
Recombinant protein containing Treponema pallid...
Fluoroquinolone; vacuolar H+ ATPase, topoisomer...
Synthetic cytokinin, plant growth regulator; fi...
Endogenous peptide, involved in vasoconstrictio...
Endogenous hormone neurotransmitter, involved i...
VEGFR inhibitor.
Endogenous tachykinin peptide, involved in infl...
Analog of staurosporine.
Aldehyde dehydrogenase, 26S proteasome, MGMT in...